Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Equillium, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +4 vs. Q1 2025
- Shares held
- 8.71M
- +147.4K (+1.7%) vs. Q1 2025
- Total value
- $2.74M
- −$609.9K (−18.2%) vs. Q1 2025
- New holders
- 6
- 6 more added
- Sold out
- 2
- 6 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Decheng Capital LLC | 4,447,308 | $1.40M | 0.35% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 1,824,977 | $575.2K | 2.94% | 00.0% | Unchanged |
| Vanguard Group Inc | 824,091 | $259.6K | 0.00% | −17,857−2.1% | Reduced |
| Cota Capital Management, LLC | 562,278 | $177.2K | 100.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 274,100 | $86.4K | 0.00% | +4,600+1.7% | Added |
| Geode Capital Management, LLC | 196,091 | $61.8K | 0.00% | −9,276−4.5% | Reduced |
| Citadel Advisors LLC | 130,705 | $41.2K | 0.00% | +75,056+134.9% | Added |
| UBS Group AG | 83,551 | $26.3K | 0.00% | +81,829+4,752.0% | Added |
| State Street Corp | 59,720 | $18.8K | 0.00% | 00.0% | Unchanged |
| AlphaCore Capital LLC | 52,345 | $16.5K | 0.00% | +52,345 | New |
| Prudential Financial Inc | 39,200 | $12.4K | 0.00% | +39,200 | New |
| Acadian Asset Management LLC | 39,475 | $12.0K | 0.00% | −69,216−63.7% | Reduced |
| Northern Trust Corp | 35,019 | $11.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 25,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 16,550 | $5.22K | 0.01% | +16,550 | New |
| Susquehanna International Group, LLP | 15,097 | $4.76K | 0.00% | +15,097 | New |
| Baader Bank INC | 23,711 | $4.62K | 0.00% | +23,711 | New |
| Apollon Wealth Management, LLC | 13,875 | $4.37K | 0.00% | +13,875 | New |
| Tritonpoint Wealth, LLC | 13,500 | $4.25K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,188 | $3.00K | 0.00% | −3,766−27.0% | Reduced |
| Morgan Stanley | 7,530 | $2.37K | 0.00% | −2,708−26.5% | Reduced |
| Tower Research Capital LLC (TRC) | 6,514 | $2.05K | 0.00% | −305−4.5% | Reduced |
| Simplex Trading, LLC | 5,075 | $1.00K | 0.00% | +3,580+239.5% | Added |
| JPMorgan Chase & Co | 1,108 | $349 | 0.00% | +1,070+2,815.8% | Added |
| Wells Fargo & Company | 1,000 | $315 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 865 | $273 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 179 | $57 | 0.00% | +28+18.5% | Added |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −39,492−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −36,967−100.0% | Sold out |
| Callan Capital, LLC | – | – | – | – | Not filed |